• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs

byArnav Agarwal, MDandAliya Ramjaun
May 14, 2019
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder

The opioid epidemic has been associated with rising hepatitis C virus (HCV) infection incidence in North America among those who inject drugs. While opioid agonist therapy may reduce HCV infection risk, the role of dosage of such therapy on this association is unclear. Given an increasing focus on global eradication of HCV infections and use of opioid agonist therapy, this prospective observational study aimed to examine the association between the prescribed dose of opioid agonist therapy and patient-perceived dosage adequacy with the risk of HCV infection among 513 adult intravenous drug users in Montreal, Canada. Participants were tested for HCV antibodies or RNA and were administered a behavioural questionnaire regarding opioid agonist therapy exposure, prescribed dosage and perceived dosage adequacy, on a 6-month basis initially, followed by a 3-month basis. Researchers found an incidence of 11.8 acquired hepatitis C infections over 100 person-years, with 168 out of 513 participants infected. The relative risk of HCV infection acquisition varied across opioid agonist treatment dosages, with those receiving high dosages (adjusted HR 0.43, 95% CI 0.23 to 0.84) and dosages perceived to be adequate (adjusted HR 0.61, 95% CI 0.25 to 1.50) having the lowest risk. Those receiving low doses perceived to be inadequate having the highest risk (adjusted HR 1.94, 95% CI 1.11 to 3.39) compared to intravenous drug users not on opioid agonist therapy. The results of this study therefore suggest that the risk of HCV infection varies considerably with dosage of opioid agonist treatment and patient-perceived adequacy of dose.

Click to read the study in CMAJ

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hepatitis Copioid abuseopioid agonist
Previous Post

Quick Take: Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study

Next Post

Campaign for restrictive marriage laws associated with increased homophobic bullying

RelatedReports

Screening insufficient for newborns exposed to hepatitis C virus
Chronic Disease

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

July 26, 2022
Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Gastroenterology

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

March 17, 2022
Adalimumab aids in control of noninfectious uveitis
Wellness

Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder

November 29, 2021
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Wellness

Wellness Check: Addictions

November 29, 2021
Next Post
Campaign for restrictive marriage laws associated with increased homophobic bullying

Campaign for restrictive marriage laws associated with increased homophobic bullying

The EXTEND trial: neurological deficits decreased with thrombolysis up to 9 hours after stroke onset

The EXTEND trial: neurological deficits decreased with thrombolysis up to 9 hours after stroke onset

Type 2 diabetes associated with reduction in disability-free life years

2 Minute Medicine Rewind May 13, 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Mental Health
  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options